Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 641

neurodegenerative diseases

Tel Aviv University researchers decode the mechanism of a rare neurological disease. From left to right, PhD student Eyal Paz, Prof. Abdussalem Azem and Prof. Uri Ashery. (Courtesy, Tel Aviv University)
December 16, 2024, 3:45 pm
Israeli researchers decode mechanism of rare neurological disease
Tel Aviv University scientists say faulty TIMM50 protein causes dysfunction in mitochondria; breakthrough could pave way for treatments for range of other conditions
By Diana Bletter
Illustrative image of a doctor comforting a patient with Alzheimer's Disease. (Chinnapong, iStock by Getty Images)
May 8, 2024, 10:24 pm
Study seeks to explain why Sephardi Jews more likely to get early-onset Alzheimer’s
NIH grants $13 million for genetic research after 2018 research showed Jews with roots in Spain, Middle East and North Africa see far more cases of early cognitive decline
By Renee Ghert-Zand
HIV virus (yellow) infecting a human cell (© Photo by National Cancer Institute on Unsplash/Courtesy of Touro University)
September 26, 2023, 2:05 pm
New research shows previously unidentified pathway used by HIV to infect cells
Study led by professor at Touro University’s Nevada campus sheds light on how AIDS-causing virus enters a cell’s nucleus so it can replicate, finds possible drug countermeasure
By Renee Ghert-Zand
Israel Prize recipient Prof. Michal Schwartz blazes a trail toward anti-aging treatment through immune therapy (Courtesy of Weizmann Institute of Science)
April 26, 2023, 6:38 am
For scientist Michal Schwartz, Israel Prize is rewarding milestone in ongoing journey
Weizmann Institute neuroimmunologist bucked convention to prove that brain is not isolated from immune system, leading to possible therapies to treat Alzheimer’s and other diseases
By Renee Ghert-Zand
File: An illustrative image of the human brain. ALS, a degenerative disease, is caused by by motor neuron death in the brain and spinal cord. (Ozgu Arslan via stock by Getty Images)
January 20, 2023, 10:51 am
New ALS drug headed to Israel, in first distribution deal outside North America
Medicine is believed to extend patients’ lives by almost a year on average; FDA has approved it based on Phase II trial
By Nathan Jeffay
ALS patient Narkis Moshe with her doctor Prof. Vivian Dror of Tel Aviv Sourasky Medical Center (courtesy of Tel Aviv Sourasky Medical Center)
December 15, 2022, 11:49 am
‘New era of treatment’: Israelis among first to receive ‘game-changing’ ALS medicine
Tofersen, which is injected into the spine like an epidural, is giving new hope to two patients at Tel Aviv Sourasky Medical Center
By Nathan Jeffay
Illustrative image of pomegranate fruit and seeds (Stephen J Perrot; iStock by Getty Images)
June 23, 2020, 3:19 pm
Nano-engineered pomegranate oil holds hope for brain disease, study shows
30 multiple sclerosis patients in Jerusalem who took antioxidant-rich food supplement for 3 months saw ‘significant cognitive improvement’
By Shoshanna Solomon
An illustrative image of neurons, or brain cells (whitehoune; iStock by Getty Images)
November 26, 2019, 12:50 pm
Israeli team uses silicon chip to deliver Alzheimer’s-busting protein to brain
In Technion, Bar-Ilan trials, nanochip ferries ‘neural growth factor’ — which combats neurodegenerative diseases — and releases it where needed, overcoming blood-brain barrier
By Shoshanna Solomon
Prof. Boaz Lerner of Ben-Gurion University of the Negev has developed an AI-based software to monitor and predict the progression of neurodegenerative diseases. (Dani Machlis)
February 25, 2019, 12:28 pm
Israeli researchers develop AI-based software to track progression of ALS
Software will later be adapted to other neurodegenerative diseases, Ben-Gurion University technology transfer arm says; BGN Tech seeks partner to further develop the technology
By Shoshanna Solomon
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.